| 1 |
The Position of Gliclazide in the Evolving Landscapes and Disease Continuum of T2DM: A Collaborative Delphi Survey-Based Consensus from India |
|
|
| Sanjay Kalra,A. G. Unnikrishnan,Ganapathi Bantwal,Sambit Das,Nareen Krishna Polavarapu,Kumar Gaurav |
|
| Diabetes Therapy. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Role of Gliclazide in Safely Navigating Type 2 Diabetes Mellitus Patients Towards Euglycemia: Expert opinion from India |
|
|
| Subhash Wangnoo,M. Shunmugavelu,Sagili Vijaya Bhaskar Reddy,Vijay Negalur,Shreerang Godbole,Vinay K Dhandhania,Nareen Krishna,Kumar Gaurav |
|
| Endocrine and Metabolic Science. 2021; : 100102 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Single Nucleotide Polymorphisms Associated with Metformin and Sulphonylureas’ Glycaemic Response among South African Adults with Type 2 Diabetes Mellitus |
|
|
| Charity Masilela,Brendon Pearce,Joven Jebio Ongole,Oladele Vincent Adeniyi,Mongi Benjeddou |
|
| Journal of Personalized Medicine. 2021; 11(2): 104 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Gliclazide alters macrophages polarization state in diabetic atherosclerosis in vitro via blocking AGE-RAGE/TLR4-reactive oxygen species-activated NF-kß nexus |
|
|
| Humera Jahan,M. Iqbal Choudhary |
|
| European Journal of Pharmacology. 2021; : 173874 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Sulfonylurea, an Update |
|
|
| Tae Nyun Kim |
|
| The Journal of Korean Diabetes. 2021; 22(2): 105 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases |
|
|
| Joăo V. S. Guerra,Marieli M. G. Dias,Anna J. V. C. Brilhante,Maiara F. Terra,Marta García-Arévalo,Ana Carolina M. Figueira |
|
| Nutrients. 2021; 13(8): 2830 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma |
|
|
| Hyunkoo Kang,Sungmin Lee,Kyeongmin Kim,Jaewan Jeon,Seok-Gu Kang,HyeSook Youn,Hae Yu Kim,BuHyun Youn |
|
| Journal of Experimental & Clinical Cancer Research. 2021; 40(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Role of Gliclazide MR in the Management of Type 2 Diabetes: Report of a Symposium on Real-World Evidence and New Perspectives |
|
|
| Kamlesh Khunti,Mohamed Hassanein,Moon-Kyu Lee,Viswanathan Mohan,Aslam Amod |
|
| Diabetes Therapy. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Role of Carnitine on Hematological Parameters and Attenuation of Cardiac (Pro)renin Receptor and Caspase-3 Expression in Hypoglycemia-induced Cardiac Hypertrophy |
|
|
| Wael A. Alanazi |
|
| International Journal of Pharmacology. 2020; 16(3): 191 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Evaluation of type 2 diabetes treatment with gliclazide modified release in Azerbaijan (the EdiAzer study): Results from a 16-week observational clinical study |
|
|
| ValehA Mirzazada,RamilaA Huseynova,SevilA Mustafayeva,FidanN Gasimova,Ulviyya Ahmadova,Narmin Ismayilova,Vafa Kerimova,Hagigat Mehdiyeva,Rana Suleymanova,Zahrakhanim Maharramova,Gulnara Iskandarli,Ofeliya Gurbanova,Sariyya Aghayeva,Sabina Malikova,Konul Ismayilova,Khanim Salimkhanova |
|
| Journal of Diabetology. 2020; 11(3): 175 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Glimepiride and Metformin Combinations in Diabetes Comorbidities and Complications: Real-World Evidence |
|
|
| Rakesh Kumar Sahay,Vinod Mittal,G Raja Gopal,Sunil Kota,Ghanshyam Goyal,Mahesh Abhyankar,Santosh Revenkar |
|
| Cureus. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020 |
|
|
| Rajeev Chawla,SV Madhu,BM Makkar,Sujoy Ghosh,Banshi Saboo,Sanjay Kalra |
|
| Indian Journal of Endocrinology and Metabolism. 2020; 24(1): 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
A real-world study in patients with type 2 diabetes mellitus treated with gliclazide modified-release during fasting: DIA-RAMADAN |
|
|
| Mohamed Hassanein,Saud Al Sifri,Shehla Shaikh,Syed Abbas Raza,Javed Akram,Agung Pranoto,Achmad Rudijanto,Inass Shaltout,Md Fariduddin,Wan Mohd Izani Wan Mohamed,Fatheya Al Awadi,Thamer Alessa |
|
| Diabetes Research and Clinical Practice. 2020; 163: 108154 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
New combination therapy of gliclazide and quercetin for protection against STZ-induced diabetic rats |
|
|
| Noha F. Abdelkader,Hebatollah E. Eitah,Yousreya A. Maklad,Amina A. Gamaleldin,Manal A. Badawi,Sanaa A. Kenawy |
|
| Life Sciences. 2020; : 117458 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Current data on the effectiveness of gliclazide and molecular mechanisms of action of the drug |
|
|
| Nina A. Petunina,Irina A. Kuzina,Ludmila V. Nedosugova |
|
| Diabetes mellitus. 2020; 23(4): 357 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
The Place of Sulfonylureas in the Evolving Landscape of Combination Therapy |
|
|
| Miao Yu |
|
| Diabetes Therapy. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020 |
|
|
| Rajeev Chawla,S. V. Madhu,B. M. Makkar,Sujoy Ghosh,Banshi Saboo,Sanjay Kalra |
|
| International Journal of Diabetes in Developing Countries. 2020; 40(S1): 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
Scientific considerations for global drug development |
|
|
| Jennifer L. Wilson,Kit Wun Kathy Cheung,Lawrence Lin,Elizabeth A. E. Green,Analia I. Porrás,Ling Zou,David Mukanga,Paul A. Akpa,Delese Mimi Darko,Rae Yuan,Sheng Ding,Wiltshire C. N. Johnson,Howard A. Lee,Emer Cooke,Carl C. Peck,Steven E. Kern,Dan Hartman,Yoshikazu Hayashi,Peter W. Marks,Russ B. Altman,Murray M. Lumpkin,Kathleen M. Giacomini,Terrence F. Blaschke |
|
| Science Translational Medicine. 2020; 12(554): eaax2550 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
The Place of Sulfonylureas in Guidelines: Why Are There Differences? |
|
|
| Aslam Amod |
|
| Diabetes Therapy. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 20 |
Introduction: Real-World Evidence in Type 2 Diabetes |
|
|
| Mohamed Hassanein,Aslam Amod,Kamlesh Khunti,Moon-Kyu Lee,Viswanathan Mohan |
|
| Diabetes Therapy. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 21 |
Missing the wood for the trees: cardiocentricity in current diabetes guidelines |
|
|
| Sanjay Kalra,Banshi Saboo,Nagendra Kumar Singh,Sarita Bajaj |
|
| International Journal of Diabetes in Developing Countries. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 22 |
A lion in the room: Has the CAROLINA trial definitely resolved the issue of the cardiovascular safety of sulfonylureas? |
|
|
| Theocharis Koufakis,George Dimitriadis,Kalliopi Kotsa |
|
| Journal of Diabetes. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 23 |
Unravelling the Utility of Modern Sulfonylureas From CVOTs and Landmark Trials: Expert Opinion from an International Panel |
|
|
| S. Kalra,S. Ghosh,A.K. Das,T. Nair,S. Bajaj,G. Priya,R.N. Mehrotra,S. Das,P. Shah,V. Deshmukh,M. Chawla,D. Sanyal,S. Chandrasekaran,D. Khandelwal,A. Joshi,F. Eliana,H. Permana,M.D. Fariduddin,P.K. Shrestha,D. Shrestha,S. Kahandawa,M. Sumanathilaka,A. Shaheed,A.A. Rahim,A. Orabi,A. Al-ani,W. Hussein,D. Kumar,K. Shaikh |
|
| Indian Heart Journal. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 24 |
Review of the results of the EASYDia international observational study. The effect of dose titration of diabeton MR on the effectiveness of treatment of type 2 diabetes |
|
|
| Natalia ?. Trubitsyna,Marina V. Shestakova |
|
| Diabetes mellitus. 2019; 22(2): 159 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 25 |
In Silico Analysis of New Potent Anti-hyperglycemic Molecule for Diabetes Type 2 Management |
|
|
| Kritika Singh,Praveen Kumar Tripathi,Vinay Kumar Singh,Ashok Kumar Patel,O. N. Srivastava,S. K. Singh,Arvind M. Kayastha |
|
| International Journal of Peptide Research and Therapeutics. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 26 |
Management of Type 2 Diabetes in Developing Countries: Balancing Optimal Glycaemic Control and Outcomes with Affordability and Accessibility to Treatment |
|
|
| Viswanathan Mohan,Kamlesh Khunti,Siew P. Chan,Fadlo F. Filho,Nam Q. Tran,Kaushik Ramaiya,Shashank Joshi,Ambrish Mithal,Maďmouna N. Mbaye,Nemencio A. Nicodemus,Tint S. Latt,Linong Ji,Ibrahim N. Elebrashy,Jean C. Mbanya |
|
| Diabetes Therapy. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 27 |
Antidiabetic agents in patients with hepatic impairment |
|
|
| Athanasia Papazafiropoulou,Andreas Melidonis |
|
| World Journal of Meta-Analysis. 2019; 7(8): 380 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 28 |
National trends in metformin-based combination therapy of oral hypoglycaemic agents for type 2 diabetes mellitus |
|
|
| Jisu Kim,Susin Park,Hyunsoo Kim,Nam Kyung Je |
|
| European Journal of Clinical Pharmacology. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 29 |
Long-Term Clinical Benefits of Canagliflozin 100 mg versus Sulfonylurea in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin in India |
|
|
| Vishal Gupta,Michael Willis,Pierre Johansen,Andreas Nilsson,Manan Shah,Amey Mane,Cheryl Neslusan |
|
| Value in Health Regional Issues. 2019; 18: 65 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 30 |
Glucocrinology of Modern Sulfonylureas: Clinical Evidence and Practice-Based Opinion from an International Expert Group |
|
|
| Sanjay Kalra,A. K. Das,M. P. Baruah,A. G. Unnikrishnan,Arundhati Dasgupta,Parag Shah,Rakesh Sahay,Rishi Shukla,Sambit Das,Mangesh Tiwaskar,G. Vijayakumar,Manoj Chawla,Fatimah Eliana,Ketut Suastika,Abbas Orabi,Aly Ahmed Abdul Rahim,Andrew Uloko,Silver Bahendeka,Abdurezak Ahmed Abdela,Fariduddin Mohammed,Faruque Pathan,Muhammed Hafizur Rahman,Faria Afsana,Shajada Selim,Muaz Moosa,Moosa Murad,Pradeep Krishna Shreshtha,Dina Shreshtha,Mimi Giri,Wiam Hussain,Ahmed Al-Ani,Kaushik Ramaiya,Surender Singh,Syed Abbas Raza,Than Than Aye,Chaminda Garusinghe,Dimuthu Muthukuda,Muditha Weerakkody,Shyaminda Kahandawa,Charlotte Bavuma,Sundeep Ruder,Koy Vanny,Manish Khanolkar,Leszek Czupryniak |
|
| Diabetes Therapy. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 31 |
BE-SMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy): Expert Opinion |
|
|
| Sarita Bajaj,A. K. Das,Sanjay Kalra,Rakesh Sahay,Banshi Saboo,Sambit Das,M. Shunmugavelu,Jubbin Jacob,Gagan Priya,Deepak Khandelwal,Deep Dutta,Manoj Chawla,Vineet Surana,Mangesh Tiwaskar,Ameya Joshi,Pradip Krishna Shrestha,Jyoti Bhattarai,Bishwajit Bhowmik,Tint Swe Latt,Than Than Aye,G. Vijayakumar,Manash Baruah,Fatema Jawad,A. G. Unnikrishnan,Subhankar Chowdhury,Md. Faruqe Pathan,Noel Somasundaram,Manilka Sumanathilaka,Abbas Raza,Silver K. Bahendeka,Ankia Coetzee,Sundeep Ruder,Kaushik Ramaiya,Roberta Lamptey,Charlotte Bavuma,Khalid Shaikh,Andrew Uloko,Sandeep Chaudhary,Abdurezak Ahmed Abdela,Zhanay Akanov,Joel Rodrěguez-Saldańa,Raquel Faradji,Armindo Tiago,Ahmed Reja,Leszek Czupryniak |
|
| Diabetes Therapy. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 32 |
Glimepiride Administered in Chow Reversibly Impairs Glucose Tolerance in Mice |
|
|
| Dana M. Niedowicz,Sabire Özcan,Peter T. Nelson |
|
| Journal of Diabetes Research. 2018; 2018: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 33 |
Bonus Effects of Antidiabetic Drugs: Possible Beneficial Effects on Endothelial Dysfunction, Vascular Inflammation and Atherosclerosis |
|
|
| Camila A. Pereira,Fernando S. Carneiro,Takayuki Matsumoto,Rita C. Tostes |
|
| Basic & Clinical Pharmacology & Toxicology. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 34 |
The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents |
|
|
| Stephen Colagiuri,David Matthews,Lawrence A. Leiter,Siew Pheng Chan,Giorgio Sesti,Michel Marre |
|
| Diabetes Research and Clinical Practice. 2018; 143: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 35 |
Modern Sulfonylureas Strike Back – Exploring the Freedom of Flexibility |
|
|
| Sanjay Kalra,Deepak Khandelwal |
|
| European Endocrinology. 2018; 14(2): 20 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 36 |
Sulfonylureas at the Glomerular Battlefield |
|
|
| Sanjay Kalra,Deepak Khandelwal,Sarita Bajaj,Ashok Kumar Das |
|
| European Endocrinology. 2018; 14(2): 15 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 37 |
Sulfonyl(thio)urea derivative induction of insulin secretion is mediated by potassium, calcium, and sodium channel signal transduction |
|
|
| Paola Miranda Sulis,Betina Fernanda Dambrós,Alessandra Mascarello,Adair Roberto Soares dos Santos,Rosendo Augusto Yunes,Ricardo José Nunes,Marisa Jádna Silva Frederico,Fátima Regina Mena Barreto Silva |
|
| Journal of Cellular Physiology. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 38 |
Effectiveness of gliclazide MR 60 mg in the management of type 2 diabetes: analyses from the EASYDia trial |
|
|
| Lawrence A. Leiter,Marina V. Shestakova,Ilhan Satman |
|
| Diabetology & Metabolic Syndrome. 2018; 10(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 39 |
Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association |
|
|
| Annabelle Santos Volgman,Latha S. Palaniappan,Neelum T. Aggarwal,Milan Gupta,Abha Khandelwal,Aruna V. Krishnan,Judith H. Lichtman,Laxmi S. Mehta,Hena N. Patel,Kevin S. Shah,Svati H. Shah,Karol E. Watson |
|
| Circulation. 2018; 138(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 40 |
Consensus recommendations on sulfonylurea and sulfonylurea combinations in the management of Type 2 diabetes mellitus – International Task Force |
|
|
| Sanjay Kalra,Silver Bahendeka,Rakesh Sahay,Sujoy Ghosh,Fariduddin Md,Abbas Orabi,Kaushik Ramaiya,Sameer Al Shammari,Dina Shrestha,Khalid Shaikh,Sachitha Abhayaratna,PradeepK Shrestha,Aravinthan Mahalingam,Mazen Askheta,AlyAhmed A. Rahim,Fatimah Eliana,HariK Shrestha,Sandeep Chaudhary,Nancy Ngugi,JeanClaude Mbanya,ThanThan Aye,TintSwe Latt,ZhanayA Akanov,AbbasRaza Syed,Nikhil Tandon,AG Unnikrishnan,SV Madhu,Ali Jawa,Subhankar Chowdhury,Sarita Bajaj,AshokKumar Das |
|
| Indian Journal of Endocrinology and Metabolism. 2018; 22(1): 132 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 41 |
Clinical practice points for diabetes management during RAMADAN fast |
|
|
| Shaukat Sadikot,K. Jothydev,A.H. Zargar,Jamal Ahmad,S.R. Arvind,Banshi Saboo |
|
| Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 42 |
New Medications for the Treatment of Diabetes |
|
|
| Satish K. Garg,Dominique Giordano,Tyler Gallo,Viral N. Shah |
|
| Diabetes Technology & Therapeutics. 2017; 19(S1): S-128 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 43 |
Mortality and Cardiovascular Risk of Sulfonylureas in South Asian, Chinese and Other Canadians with Diabetes |
|
|
| Calvin Ke,Steve Morgan,Kate Smolina,Danijela Gasevic,Hong Qian,Nadia Khan |
|
| Canadian Journal of Diabetes. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 44 |
Efficacy and safety of liraglutide compared to sulphonylurea during Ramadan in patients with type 2 diabetes (LIRA-Ramadan): a randomized trial |
|
|
| S. T. Azar,A. Echtay,W. M. Wan Bebakar,S. Al Araj,A. Berrah,M. Omar,A. Mutha,K. Tornře,M. S. Kaltoft,N. Shehadeh |
|
| Diabetes, Obesity and Metabolism. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 45 |
Challenges in diabetes mellitus type 2 management in Nepal: a literature review |
|
|
| Bishal Gyawali,Alessandra Ferrario,Edwin van Teijlingen,Per Kallestrup |
|
| Global Health Action. 2016; 9(1): 31704 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 46 |
Genetic variations in TCF7L2 influence therapeutic response to sulfonylureas in Indian diabetics |
|
|
| Dipali Dhawan,Harish Padh |
|
| Diabetes Research and Clinical Practice. 2016; 121: 35 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
